Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the six research firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating, three have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is GBX 2,010 ($25.02).
JMAT has been the topic of several recent analyst reports. Numis Securities reissued a “buy” rating and set a GBX 2,200 ($27.39) target price on shares of Johnson Matthey in a research note on Wednesday, March 20th. Jefferies Financial Group reissued a “buy” rating and set a GBX 2,100 ($26.14) target price on shares of Johnson Matthey in a research note on Wednesday, March 20th. Finally, Berenberg Bank raised their price target on Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the company a “hold” rating in a report on Monday, April 8th.
Check Out Our Latest Stock Report on Johnson Matthey
Johnson Matthey Stock Up 0.6 %
Insider Buying and Selling at Johnson Matthey
In related news, insider Liam Condon bought 24 shares of the company’s stock in a transaction dated Wednesday, April 17th. The stock was purchased at an average price of GBX 1,767 ($22.00) per share, for a total transaction of £424.08 ($527.92). In related news, insider Liam Condon bought 24 shares of the company’s stock in a transaction dated Wednesday, April 17th. The stock was purchased at an average price of GBX 1,767 ($22.00) per share, for a total transaction of £424.08 ($527.92). Also, insider Stephen Oxley bought 18 shares of the company’s stock in a transaction dated Wednesday, March 20th. The stock was bought at an average price of GBX 1,864 ($23.20) per share, with a total value of £335.52 ($417.68). Insiders bought 66 shares of company stock worth $114,288 in the last quarter. 0.60% of the stock is owned by corporate insiders.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Read More
- Five stocks we like better than Johnson Matthey
- Using the MarketBeat Stock Split Calculator
- Comprehensive PepsiCo Stock Analysis
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What is an Earnings Surprise?
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.